Stay updated on EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.

Latest updates to the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed, a minor metadata update with no changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a Locations section listing California as a location. Removed the California Locations entry and the HHS Vulnerability Disclosure section, and updated the page revision from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check47 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1; no user-facing content appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedThe government funding/operating status banner at the top of the page was removed.SummaryDifference0.3%

- Check75 days agoChange DetectedResults have been posted for the study (Results First Posted 2025-04-16) and the record shows updated dates, indicating completion and availability of outcome data.SummaryDifference0.4%

Stay in the know with updates to EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.